Revenue Recognition (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
	Jul. 13, 2022	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Disaggregation of Revenue [Line Items]
Net revenue		$ 80,992	$ 108,220	$ 157,364	$ 198,279
UNITED STATES | Net Product Sales | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration Risk, Percentage		94.00%		96.00%
GIAPREZA
Disaggregation of Revenue [Line Items]
Net revenue		$ 11,200		$ 20,200
XERAVA
Disaggregation of Revenue [Line Items]
Net revenue		4,500		7,000
GSK
Disaggregation of Revenue [Line Items]
Percentage of royalty payments not entitled to receive	15.00%
Net revenue		62,265	$ 108,220	119,123	$ 198,279
La Jolla
Disaggregation of Revenue [Line Items]
Net revenue		$ 15,700		$ 27,200